reiterateINVAfinnhub
Oppenheimer Reiterates Outperform Rating on Innoviva, Inc. (INVA)
Oppenheimer reiterated its Outperform rating on Innoviva, Inc. (NASDAQ:INVA) on November 05, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Oppenheimer reiterated its Outperform rating on Innoviva, Inc. (NASDAQ:INVA) on November 05, 2026.
Read moreTD Cowen reiterated its Buy rating on Schrödinger, Inc. (NASDAQ:SDGR) on November 05, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Teladoc Health, Inc. (NYSE:TDOC) on November 05, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on PureCycle Technologies, Inc. (NASDAQ:PCTTU) on November 05, 2026.
Read moreStephens & Co. reiterated its Equal-Weight rating on Papa John's International, Inc.
Read moreNeedham reiterated its Buy rating on N-able, Inc. (NYSE:NABL) on November 05, 2026.
Read moreWells Fargo reiterated its Overweight rating on American Financial Group, Inc. (NYSE:AFGE) on November 05, 2026.
Read moreFreedom Broker analysts upgraded Tennant Company (NYSE:TNC) from Hold to Buy on November 05, 2026.
Read moreWells Fargo reiterated its Underweight rating on Marriott Vacations Worldwide Corporation (NYSE:VAC) on November 05, 2026.
Read moreBarclays reiterated its Overweight rating on Marriott Vacations Worldwide Corporation (NYSE:VAC) on November 05, 2026.
Read moreLeerink Partners reiterated its Market Perform rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) on November 05, 2026.
Read moreNeedham reiterated its Buy rating on Power Integrations, Inc. (NASDAQ:POWI) on November 05, 2026.
Read moreSusquehanna reiterated its Positive rating on Power Integrations, Inc. (NASDAQ:POWI) on November 05, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on November 05, 2026.
Read moreNeedham reiterated its Buy rating on Vishay Intertechnology, Inc. (NYSE:VSH) on November 05, 2026.
Read moreStoneX reiterated its Buy rating on The Andersons, Inc. (NASDAQ:ANDE) on November 05, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Progyny, Inc. (NASDAQ:PGNY) on November 05, 2026.
Read moreCitizens reiterated its Market Outperform rating on Progyny, Inc. (NASDAQ:PGNY) on November 05, 2026.
Read moreLeerink Partners reiterated its Outperform rating on Progyny, Inc. (NASDAQ:PGNY) on November 05, 2026.
Read moreWells Fargo reiterated its Overweight rating on Progyny, Inc. (NASDAQ:PGNY) on November 05, 2026.
Read more